Harrow (HROW) Change in Acquisitions & Divestments (2013)
Harrow (HROW) posted quarterly Change in Acquisitions & Divestments of -$50000.0 for Q1 2013.
Harrow (HROW) Change in Acquisitions & Divestments (2013) Analysis & Trends
Harrow's Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at -$50000.0 for Q1 2013.
- In Q1 2013, Change in Acquisitions & Divestments changed N/A year-over-year to -$50000.0; the TTM figure through Dec 2013 stood at -$50000.0 (changed N/A YoY), while the FY2024 annual figure was $5.5 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments for Q1 2013 stood at -$50000.0.
- The five-year high for Change in Acquisitions & Divestments was -$50000.0 in Q1 2013, with the low at -$50000.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Harrow | 1.53 Bn | 1.45 Bn | 50.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | -50,000.00 |
| Mar 31, 2013 | -50,000.00 |